Post-stroke Upper Limb Spasticity
📧 Sign up to get email alerts when something new happens for Post-stroke Upper Limb Spasticity.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-08-01Clinical Trial Update: Effectiveness and Safety of SMART [Spastic Muscle Palpation by Anatomic Landscape for BoNT-A (Botulinumtoxin-A) Injection to Reduce Muscle Tone] BoNT-A Therapy With Dysport® in Patients With Post-stroke Chronic Upper Limb Spasticity (ULS) in Real-life Setting.
Real-world study evaluating the effectiveness and safety of SMART-guided Dysport (abobotulinumtoxinA) injections for reducing muscle tone in…
-
CLINICAL_TRIALS trial_result · 2023-08-01Clinical Trial Update: To Evaluate HU-014 in the Treatment of Post Stroke Upper Limb [Phase 3]
Phase 3 trial evaluating HU-014 for post-stroke upper limb spasticity has completed.
-
CLINICAL_TRIALS trial_result · 2019-04-09Clinical Trial Update: MEDITOXIN® Treatment in Subjects With Post-Stroke Upper Limb Spasticity [Phase 4]
Phase 4 clinical trial update for MEDITOXIN in subjects with post-stroke upper limb spasticity has completed.
-
CLINICAL_TRIALS trial_result · 2012-05-17Clinical Trial Update: A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of GSK1358820 (Botulinum Toxin Type A) in Chinese Subjects With Post-stroke Upper Limb Spasticity [Phase 3]
Phase 3 multicenter, double-blind, randomized, placebo-controlled trial evaluating GSK1358820 (botulinum toxin type A) for post-stroke upper…
-
CLINICAL_TRIALS trial_result · 2010-09-28Clinical Trial Update: IncobotulinumtoxinA (Xeomin) Versus Placebo in the Treatment of Post-stroke Spasticity of the Upper Limb [Phase 3]
Phase 3 trial comparing incobotulinumtoxinA (Xeomin) to placebo for post-stroke upper limb spasticity completed; results posted in 2010.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.